Related references
Note: Only part of the references are listed.Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy
Yue Zhao et al.
ONCOIMMUNOLOGY (2018)
Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover
Brent E. Fitzwalter et al.
DEVELOPMENTAL CELL (2018)
Microenvironmental autophagy promotes tumour growth
Nadja S. Katheder et al.
NATURE (2017)
Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a
Wei Qiang et al.
ENDOCRINE (2017)
MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1
L. Shi et al.
BRITISH JOURNAL OF CANCER (2014)
LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G2/M phase arrest and cell apoptosis in MCF-7 humanbreast cancer cells in vitro and in vivo
Lei Tao et al.
TOXICOLOGY LETTERS (2014)
Effect of Danofloxacin on Reactive Oxygen Species Production, Lipid Peroxidation and Antioxidant Enzyme Activities in Kidney Tubular Epithelial Cell Line, LLC-PK1
Chun-Hong Yu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia
L-N Zhang et al.
CANCER GENE THERAPY (2013)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim
Jieru Meng et al.
PLOS ONE (2010)
BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3
Amanda Nordigarden et al.
BLOOD (2009)
Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis)
Ravinder Sappal et al.
VETERINARY RESEARCH COMMUNICATIONS (2009)
Inhibition of glioblastoma growth and angiogenesis by garnbogic acid: An in vitro and in vivo study
Lei Qiang et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
Mark S. Cragg et al.
PLOS MEDICINE (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D
M Schmidt et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Intranuclear localization of apoptosis-inducing factor (AIF) and large scale dna fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite
XP Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis
R Sundararajan et al.
JOURNAL OF VIROLOGY (2001)
Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis
A Nechushtan et al.
JOURNAL OF CELL BIOLOGY (2001)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
BH3-Only proteins - Essential initiators of apoptotic cell death
DCS Huang et al.
CELL (2000)
Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c
SJ Korsmeyer et al.
CELL DEATH AND DIFFERENTIATION (2000)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
PF Dijkers et al.
CURRENT BIOLOGY (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
Share Paper
